TABLE 2.
Method | ACC (%) | PPV (%) | NPV (%) | SEN (%) | SPE (%) | AUC | F1 (%) | p |
Baseline | 75.74 ± 2.96 | 83.79 ± 2.32 | 59.84 ± 13.06 | 80.79 ± 4.89 | 64.92 ± 2.09 | 0.7332 ± 0.0602 | 82.26 ± 1.53 | – |
Baseline + BP | 78.48 ± 3.44 | 86.21 ± 4.22 | 63.29 ± 4.18 | 82.24 ± 2.03 | 70.29 ± 7.26 | 0.7629 ± 0.0719 | 84.17 ± 2.70 | 0.068 |
Tri-loss | 77.35 ± 5.28 | 87.93 ± 5.72 | 56.34 ± 19.67 | 80.49 ± 6.45 | 71.3 ± 8.60 | 0.7415 ± 0.0963 | 84.05 ± 3.41 | 0.342 |
Tri-loss + BP | 79.64 ± 3.11 | 89.31 ± 2.56 | 60.55 ± 9.54 | 81.84 ± 3.66 | 74.29 ± 4.18 | 0.7589 ± 0.0633 | 85.41 ± 2.13 | 0.013* |
Con-loss | 77.81 ± 3.05 | 86.55 ± 3.57 | 59.17 ± 9.13 | 80.88 ± 3.37 | 70.53 ± 5.67 | 0.7387 ± 0.0801 | 83.94 ± 2.22 | 0.342 |
Con-loss + BP | 79.40 ± 1.92 | 86.90 ± 6.41 | 64.67 ± 10.58 | 83.22 ± 3.86 | 72.43 ± 6.59 | 0.7707 ± 0.0848 | 85.01 ± 1.89 | 0.079 |
The bold values represent the highest number.
The asterisk represents the results have the statistical significance.